SunOpta Inc. (NASDAQ:STKL) shares traded down 3.2% during trading on Wednesday . The company traded as low as $5.04 and last traded at $5.11, with a volume of 409,943 shares changing hands. The stock had previously closed at $5.28.

A number of research analysts have commented on the stock. Zacks Investment Research raised shares of SunOpta from a “sell” rating to a “hold” rating in a research report on Wednesday, May 4th. Canaccord Genuity restated a “buy” rating and issued a $10.00 price target on shares of SunOpta in a report on Wednesday, April 13th. DA Davidson upgraded shares of SunOpta from a “neutral” rating to a “buy” rating and set a $6.00 price target on the stock in a report on Wednesday, April 13th. Finally, AltaCorp Capital restated an “outperform” rating on shares of SunOpta in a report on Tuesday, June 21st. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $9.50.

The company has a 50 day moving average price of $4.54 and a 200-day moving average price of $5.07. The company’s market capitalization is $431.82 million.

SunOpta (NASDAQ:STKL) last posted its earnings results on Tuesday, May 10th. The company reported $0.03 EPS for the quarter, missing the Zacks’ consensus estimate of $0.04 by $0.01. The business had revenue of $352.30 million for the quarter, compared to the consensus estimate of $351.60 million. During the same quarter in the prior year, the firm earned $0.08 earnings per share. SunOpta’s revenue was up 16.1% compared to the same quarter last year. On average, equities analysts anticipate that SunOpta Inc. will post $0.24 earnings per share for the current fiscal year.

In related news, Director Douglas Greene bought 50,000 shares of the firm’s stock in a transaction on Friday, May 20th. The shares were bought at an average price of $3.77 per share, with a total value of $188,500.00. Following the completion of the transaction, the director now directly owns 265,543 shares of the company’s stock, valued at approximately $1,001,097.11. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Hendrik Jacobs bought 7,000 shares of the firm’s stock in a transaction on Friday, May 20th. The stock was bought at an average cost of $3.85 per share, for a total transaction of $26,950.00. Following the transaction, the chief executive officer now directly owns 41,638 shares of the company’s stock, valued at $160,306.30. The disclosure for this purchase can be found here.

Other hedge funds have modified their holdings of the company. Dimensional Fund Advisors LP raised its stake in shares of SunOpta by 56.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 151,928 shares of the company’s stock worth $1,039,000 after buying an additional 54,539 shares during the period. Baker Chad R acquired a new stake in shares of SunOpta during the fourth quarter worth about $2,977,000. Jennison Associates LLC raised its stake in shares of SunOpta by 6.8% in the fourth quarter. Jennison Associates LLC now owns 4,234,596 shares of the company’s stock worth $28,965,000 after buying an additional 270,963 shares during the period. Finally, Morgan Stanley raised its stake in shares of SunOpta by 123,646.6% in the fourth quarter. Morgan Stanley now owns 6,693,454 shares of the company’s stock worth $45,783,000 after buying an additional 6,688,045 shares during the period.

SunOpta Inc operates businesses focused on a healthy products portfolio. The Company operates through two segments: Global Ingredients and Consumer Products. Its Global Ingredients segment aggregates its North American and international raw material sourcing and supply operating segments focused on the procurement, processing and sale of specialty and organic grains and seeds, fruits, grain- and cocoa-based ingredients, and other commodities.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.